Abstract:and much work needs to be done to identify the causes of regional variability. Finally, it needs to be emphasized that "fistula first" does not mean "fistula only." Patients with poor likelihood of maturation of a fistula, or a short life expectancy, may be better candidates for a graft.Complex Plaques in the Proximal Descending Aorta: An Underestimated Embolic Source of Stroke Harloff A, Simon J, Brendecke S, et al. Stroke 2010;41:1145-50. Conclusion: Retrograde flow from complex descending aorta plaques i… Show more
“…In patients with PAD specifically, comprehensive smoking cessation programs that included individualized counseling and pharmacological support significantly increased the rate of smoking cessation at 6 months compared with verbal advice to quit smoking (21.3% versus 6.8%, Pϭ0.02). 29 Tobacco cessation interventions are particularly critical in individuals with thromboangiitis obliterans, because it is presumed that components of tobacco may be causative in the pathogenesis of this syndrome, and continued use is associated with a particularly adverse outcome. 42 Table 4 contains recommendations for antiplatelet and antithrombotic drugs.…”
Section: Recommendations For Smoking Cessationmentioning
*Writing group members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information. †ACCF/AHA Representative.
“…In patients with PAD specifically, comprehensive smoking cessation programs that included individualized counseling and pharmacological support significantly increased the rate of smoking cessation at 6 months compared with verbal advice to quit smoking (21.3% versus 6.8%, Pϭ0.02). 29 Tobacco cessation interventions are particularly critical in individuals with thromboangiitis obliterans, because it is presumed that components of tobacco may be causative in the pathogenesis of this syndrome, and continued use is associated with a particularly adverse outcome. 42 Table 4 contains recommendations for antiplatelet and antithrombotic drugs.…”
Section: Recommendations For Smoking Cessationmentioning
*Writing group members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information. †ACCF/AHA Representative.
“…A physician advice coupled with frequent follow-up achieves 1-year smoking cessation rates of approximately 5% compared with only 0.1% in individuals who try to quit smoking without a physician's intervention (16). In patients with PAOD, comprehensive smoking cessation programs that included individualized counseling and pharmacological support significantly increased the rate of smoking cessation at 6 months compared with verbal advice to quit smoking (21.3% versus 6.8%, p<0.02) (17). Therefore the focused update of the guideline for the management of smoking patients recommended that current smokers or former smokers should be asked about their status of tobacco use at every visit (Level of Evidence: A).…”
“…A meta-analysis of successful smoking cessation intervention studies suggests that factors associated with success included face-to-face counseling, advice from both providers and nonphysician counselors, and the number of sessions, with more being better (12). These aspects are key components of the randomized clinical trial conducted by Hennrikus et al (13) in this issue of the Journal.…”
Section: See Page 2105mentioning
confidence: 99%
“…Hennrikus et al (13) reports a randomized trial using a smoking cessation program for patients with PAD. Patients with documented PAD who were identified as current smokers were eligible for the study.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.